PRIME-X MELATONIN IMPLANTS DIN 00793167
Status: Marketed
Holder: NEO-DYNAMICS
Health Canada record
| Active ingredient(s) | MELATONIN 2.7 MG |
|---|
| Dosage form | Implant |
|---|
| Route | Subcutaneous |
|---|
| Schedule | NON-PRESCRIPTION DRUGS |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 31-Dec-1988 |
|---|
| Current status date | 01-Jul-2025 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MELATONIN
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02560798 | SLENYTO | NEURIM PHARMACEUTICALS LTD. | Tablet (Extended-Release) | MELATONIN 1 MG | Marketed |
| 02560801 | SLENYTO | NEURIM PHARMACEUTICALS LTD. | Tablet (Extended-Release) | MELATONIN 5 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 6586 | 1999-06-04 | New Drug Submission (NDS) | |
International API supply for MELATONIN
2 valid EDQM Certificates of Suitability from 2 holders. 4 active FDA Drug Master Files.
Request a quote for PRIME-X MELATONIN IMPLANTS
How to read a Canadian DIN record